New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 24, 2022 - Prasco launched an authorized brand alternative of GSK’s Breo Ellipta (fluticasone furoate/vilanterol trifenatate) inhalation aerosol.
Download PDF
Return to publications
